SPIA
BMY.RT

Steward Partners Investment Advisory’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Steward Partners Investment Advisory’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,243
Closed -$3K – 3544
2020
Q4 		$3K Sell
4,243
-14,312
-77% -$30.5K ﹤0.01% 2673
2020
Q3 		$42K Sell
18,555
-93
-0.5% -$266 ﹤0.01% 1580
2020
Q2 		$67K Buy
18,648
+780
+4% +$2.81K ﹤0.01% 1301
2020
Q1 		$67K Sell
17,868
-395
-2% -$1.3K ﹤0.01% 1162
2019
Q4 		$54K Buy
+18,263
New +$47.5K ﹤0.01% 1361

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Steward Partners Investment Advisory's BMY.RT Position: Q1 2021 in Review

Steward Partners Investment Advisory sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 4,243 shares — an estimated $3K sold.

Steward Partners Investment Advisory first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $67K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Steward Partners Investment Advisory reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 4,243 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $3K.
  • Steward Partners Investment Advisory first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Steward Partners Investment Advisory's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $67K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2021, filed 14 May 2021.